Help Privacy Policy Disclaimer
  Advanced SearchBrowse




Journal Article

Bioluminescent antibodies for point-of-care diagnostics


Johnsson,  Kai
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available

Xue, L., Yu, Q., Griss, R., Schena, A., & Johnsson, K. (2017). Bioluminescent antibodies for point-of-care diagnostics. Angewandte Chemie International Edition, 56(25), 7112-7116. doi:10.1002/anie.201702403.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-C1A8-F
We introduce a general method to transform antibodies into ratiometric, bioluminescent sensor proteins for the no-wash quantification of analytes. Our approach is based on the genetic fusion of antibody fragments to NanoLuc luciferase and SNAP-tag, the latter being labeled with a synthetic fluorescent competitor of the antigen. Binding of the antigen, here synthetic drugs, by the sensor displaces the tethered fluorescent competitor from the antibody and disrupts bioluminescent resonance energy transfer (BRET) between the luciferase and fluorophore. The semisynthetic sensors display a tunable response range (submicromolar to submillimolar) and large dynamic range (ΔRmax >500 %), and they permit the quantification of analytes through spotting of the samples onto paper followed by analysis with a digital camera.